Acute Lymphoblastic Leukemia: Optimizing MRD Testing
0 Bekeken
• 06/15/23
0
0
insluiten
administrator
abonnees
Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties